At 16.6% CAGR, the South & Central America Cell and Gene Therapy Manufacturing Services Market is Projected to be worth US$ 981.18 million by 2030, says Business Market Insights

According to Business Market Insights research, the South & Central America cell and gene therapy manufacturing services market was valued at US$ 286.83 million in 2022 and is expected to reach US$ 981.18 million by 2030, registering a CAGR of 16.6% from 2022 to 2030. Increase in number of approvals of cell and gene therapies and increasing popularity of outsourcing cell and gene therapy manufacturing are the critical factors attributed to the South & Central America cell and gene therapy manufacturing services market expansion.               

The advancements in biotechnology have led to the adoption of personalized treatments for a wide range of indications. Stem cell therapies are being used to treat chronic diseases, such as cancer, neurological disorders, and genetic disorders. Further, the advantages of cell therapy, such as targeted treatment, faster and efficient recovery, and reduced side effects, promote the adoption of various products. Therefore, the increasing approval of cell and gene therapies is fueling the growth of cell and gene therapy manufacturing services market.

On the contrary, high cost of cell and gene therapy manufacturing hurdles the growth of South & Central America cell and gene therapy manufacturing services market.

Based on type, the South & Central America cell and gene therapy manufacturing services market is bifurcated into cell therapy and gene therapy. The cell therapy segment held 67.2% share of South & Central America cell and gene therapy manufacturing services market in 2022, amassing US$ 192.70 million. It is projected to garner US$ 668.06 million by 2030 to expand at 16.8% CAGR during 2022–2030. The cell therapy segment is further segmented into autologous and allogenic. The gene therapy segment is further segmented into viral and non-viral vector.

Based on indication, the South & Central America cell and gene therapy manufacturing services market is segmented into cancer, orthopedics, and others. The cancer segment held 52.7% share of South & Central America cell and gene therapy manufacturing services market in 2022, amassing US$ 151.13 million. It is projected to garner US$ 551.61 million by 2030 to expand at 17.6% CAGR during 2022–2030.

Based on application, the South & Central America cell and gene therapy manufacturing services market is segmented into clinical manufacturing and commercial manufacturing. The commercial manufacturing segment held 64.2% share of South & Central America cell and gene therapy manufacturing services market in 2022, amassing US$ 184.23 million. It is projected to garner US$ 663.77 million by 2030 to expand at 17.4% CAGR during 2022–2030.  

Based on end user, the South & Central America cell and gene therapy manufacturing services market is bifurcated into pharmaceutical and biotechnology companies and contract research organization (CROs). The pharmaceutical and biotechnology companies segment held 78.8% share of South & Central America cell and gene therapy manufacturing services market in 2022, amassing US$ 226.09 million. It is projected to garner US$ 779.16 million by 2030 to expand at 16.7% CAGR during 2022–2030.

Based on country, the South & Central America cell and gene therapy manufacturing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 64.0% share of South & Central America cell and gene therapy manufacturing services market in 2022. It was assessed at US$ 183.49 million in 2022 and is likely to hit US$ 631.82 million by 2030, exhibiting a CAGR of 16.7% during 2022–2030.  

Key players operating in the South & Central America cell and gene therapy manufacturing services market are Catalent Inc, Charles River Laboratories International Inc, FUJIFILM Holdings Corp, Lonza Group AG, Merck KgaA, Nikon Corp, Takara Bio Inc, and Thermo Fisher Scientific Inc, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com